Single-stranded oligonucleotides can inhibit cytokine production induced by human toll-like receptor 3

Molecular and Cellular Biology

Volumn 28, Issue 14, 2008, Pages 4507-4519

  Ranjith Kumar, C T ^a   Duffy, K E ^b   Jordan, J L ^b   Eaton Bassiri, A ^b,c   Vaughan, Robert ^a   Hoose, Scott A ^a   Lamb, Roberta J ^b   Sarisky, R T ^b   Kao, C Cheng ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b CENTOCOR INC   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DOUBLE STRANDED DNA; POLYINOSINIC POLYCYTIDYLIC ACID; SINGLE STRANDED DNA; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE; TLR3 PROTEIN, HUMAN;

ARTICLE; BRONCHUS MUCOSA; CELL STRAIN HEK293; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DNA DETERMINATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; CELL LINE; CHEMISTRY; ENDOSOME; GENETICS; IMMUNOLOGY; MONONUCLEAR CELL; REPORTER GENE;

CELL LINE; CYTOKINES; DNA, SINGLE-STRANDED; ENDOSOMES; GENES, REPORTER; HUMANS; LEUKOCYTES, MONONUCLEAR; NF-KAPPA B; OLIGONUCLEOTIDES; POLY I-C; TOLL-LIKE RECEPTOR 3;

EID: 47049114564     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00308-08     Document Type: Article

References (40)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732-738.
3. Bagchi, A., E. A. Herrup, H. S. Warren, J. Trigilio, H. S. Shin, C. Valentine, and J. Hellman. 2006. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 178:1164-1171.
4. Bauer, S., C. J. Kirschnin, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, and G. B. Lipford. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98:9237-9242.
5. Beadling, C., and M. K. Slifka. 2004. How do viral infections predispose patients to bacterial infections? Curr. Opin. Infect. Dis. 17:185-191.
6. Bell, J. K., J. Askins, P. R. Hall, and D. Davies. 2006. The dsRNA binding site of human Toll-like receptor 3. Proc. Natl. Acad. Sci. USA 103:8792-8797.
7. Bhardwaj, K., S. Palaninathan, J. M. Alcantara, L. Li Yi, L. Guarino, J. C. Sacchettini, and C. C. Kao. 2008. Structural and functional analyses of the severe acute respiratory syndrome coronavirus endoribonuclease nsp15. J. Biol. Chem. 283:3655-3664.
8. Carpenter, S., and L. A. O'Neill. 2007. How important are Toll-like receptors for antimicrobial responses? Cell Microbiol. 9:1891-1901.
9. Cook, D. N., D. S. Pisetsky, and D. A. Schwartz. 2004. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5:975-979.
10. de Bouteiller, O., E. Merck, U. A. Hasan, S. Hubac, B. Benguigui, G. Trinchieri, E. E. M. Bates, and C. Caux. 2005. Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J. Biol. Chem. 280:38133-38145.
11. Dorn, A., R. J. Ludwig, A. Bock, D. Thaci, K. Hardt, J. Bereiter-Hahn, R. Kaufmann, A. Bernd, and S. Kippenberger. 2007. Oligonucleotides suppress IL-8 skin keratinocytes in vitro and offer anti-inflammatory properties in vivo. J. Investig. Dermatol. 127:846-854.
12. Duffy, K. E., R. J. Lamb, L. R. San Mateo, J. L. Jordan, G. Canziani, M. Brigham-Burke, J. Korteweg, M. Cunningham, H. S. Beck, J. Carton, J. Giles-Kumar, C. Duchala, R. T. Sarisky, and M. L. Mbow. 2007. Down modulation of human TLR3 function by a monoclonal antibody. Cell. Immunol. 248:103-114.
13. Gaspari, A. A. 2006. Innate and adaptive immunity in the pathophysiology of psoriasis. J. Am. Acad. Dermatol. 54:S67-S80.
14. Gay, N. J., and M. Gangloff. 2007. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76:141-165.
15. Hartmann, G., and A. M. Krieg. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary cells. J. Immunol. 164:944-952.
16. Hartmann, G., R. D. Weeratna, Z. K. Ballas, P. Payette, S. Blackwell, I. Suparto, W. L. Rasmussen, M. Waldschmidt, D. Sajuthi, R. H. Purcell, H. L. Davis, and A. M. Krieg. 2000. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164:1617-1624.
17. Heeg, K., A. Dalpke, M. Peter, and S. Zimmermann. 2007. Structural requirements for uptake and recognition of CpG oligonucleotides. Int. J. Med. Microbiol. 298:33-38.
18. Jurk, M., A. Kritzler, B. Schulte, S. Tluk, C. Schetter, A. M. Krieg, and J. Vollmer. 2006. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides. Eur. J. Immunol. 36:1815-1826.
19. Jurk, M., F. Heil, J. Vollmer, C. Schetter, A. M. Krieg, H. Wagner, G. Lipford, and S. Bauer. 2002. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3:499.
20. Kabelitz, D. 2007. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19:39-45.
21. Kariki, K., H. Ni, J. Capodici, M. Lamphier, and D. Weissman. 2004. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279:12542-12550.
22. Kawai, T., and S. Akira. 2005. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17:338-344.
23. Kawai, T., and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131-137.
24. Kim, Y. C., W. K. Russell, C. T. Ranjith-Kumar, M. Thomson, D. H. Russell, and C. C. Kao. 2005. Functional analysis of RNA binding by the hepatitis C virus RNA-dependent RNA polymerase. J. Biol. Chem. 280:38011-38019.
25. Kindrachuk, J., J. E. Potter, R. Brownlie, A. D. Ficzyc, P. J. Griebel, N. Mookherjee, G. K K. Mutwiri, L. A. Babiuk, and S. Napper. 2007. Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-Like receptor 9. J. Biol. Chem. 282:13944-13953.
26. Kobayashi, M., Y. Tsuda, T. Yoshida, D. Takeuchi, T. Utsunomiya, H. Takahashi, and F. Suzuki. 2006. Bacterial sepsis and chemokines. Curr. Drug Targets 7:119-134.
27. Lancaster, G. I., Q. Khan, P. Drysdale, F. Wallace, A. E. Jeukendrup, M. T. Drayson, and M. Gleeson. 2005. The physiological regulation of Toll-like receptor expression and function in humans. J. Physiol. 563:945-955.
28. Leonard, J. N., R. Ghiriando, J. Askins, J. K. Bell, D. H. Margulies, D. R. Davies, and D. M. Segal. 2008. The TLR3 signaling complex forms by cooperative receptor dimerization. Proc. Natl. Acad. Sci. USA 105:258-263.
29. Limmon, G. V., M. Arredouani, K. L. McCann, R. A. C. Minor, L. Kobzik, and F. Imani. 2008. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J. 22:159-167.
30. Matsukura, S., F. Kokubu, M. Kurokawa, M. Kawaguchi, K. Ieki, H. Kuga, M. Odaka, S. Suzuki, S. Watanabe, H. Takeuchi, T. Kasama, and M. Adachi. 2006. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells. Clin. Exp. Allergy 36:1049-1062.
31. Matsumoto, M., K. Funami, M. Tanabe, H. Oshiumi, M. Shingai, Y. Seto, A. Yamamoto, and T. Seya. 2006. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171:3154-3162.
32. Napolitani, G., A. Rinaldi, F. Hertoni, F. Sallusto, and A. Lanzavecchia. 2006. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6:769-776.
33. Ranjith-Kumar, C. T., W. Miller, J. Sun, J. Xiong, J. Santos, I. Yarbrough, R. J. Lamb, J. Mills, K. E. Duffy, S. Hoose, M. Cunningham, A. Holzenburg, M. L. Mbow, R. T. Sarisky, and C. C. Kao. 2007. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J. Biol. Chem. 282:17696-176705.
34. Ranjith-Kumar, C. T., W. Miller, J. Xiong, W. K. Russell, R. Lamb, J. Santos, K. E. Duffy, L. Cleveland, M. Park, K. Bhardwaj, Z. Wu, D. H. Russell, R. T. Sarisky, M. L. Mbow, and C. C. Kao. 2007. Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J. Biol. Chem. 282:7668-7678.
35. Schroder, K., M. Spille, A. Pilz, J. Lattin, K. A. Bode, K. M. Irvine, A. D. Burrows, T. Ravasi, H. Weighardt, K. J. Stacey, D. A. Hume, A. H. Dalpke, and M. J. Sweet. 2007. Differential effects of CpG DNA on IFN-induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages. J. Immunology 179:3495-3503.
36. Shinozuka, K., T. Merita, and H. Sawai. 1991. Synthesis and nuclease susceptibility of alpha-oligodeoxyribonucleotide phosphorothioate. Nucleic Acids Symp. Ser. 25:101-102.
37. Sun, J., K. E. Duffy, C. T. Ranjith-Kumar, J. Xiong, R. J. Lamb, J. Santos, H. Masarapu, M. Cunningham, A. Holzenburg, R. T. Sarisky, M. L. Mbow, and C. Kao. 2006. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J. Biol. Chem. 281:11144-11151.
38. Uematsu, S., and S. Akira. 2006. Toll-like receptors and innate immunity. J. Mol. Med. 84:712-725.
39. Underhill, D. M. 2004. Toll-like receptors and microbes take aim at each other. Curr. Opin. Immunol. 16:483-487.
40. Yu, D., E. R. Kandimalla, Y. Cong, J. Tang, J. Y. Tang, Q. Zhao, and S. Agrawal. 2002. Design, synthesis, and immunostimulatory properties of CpG DNAs containing alkyl-linker substitutions: role of nucleosides in the flanking sequences. J. Med. Chem. 45:4540-4548.